ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

The Current Role of Checkpoint Inhibitors in Head and Neck Cancer

Everett E. Vokes, MD
Published Online:10:06 AM, Tue October 10, 2017
Everett E. Vokes, MD, John E. Ultmann Professor of Medicine and Radiation Oncology, Physician-in-Chief, University of Chicago Medicine and Biological Sciences, Chair, Department of Medicine, discusses the current role of checkpoint inhibitors for the treatment of head and neck cancer during the ESMO 2017 Congress.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.